Articles tagged with "adalimumab"

Upadacitnib for RA: Researchers Compared Upadacitinib with Placebo & Adalimumab in Patients with RA & an Inadequate Response to Methotrexate

March 9, 2021 • By Vanessa Caceres

Oxford University to Study Adalimumab as Potential COVID-19 Treatment

September 30, 2020 • By Josephine Mason & Kate Kelland

Biologic Spending & Price Trends

January 28, 2020 • By Arthritis & Rheumatology

Humira, Rituxan Top List of U.S. Drugs with Biggest Price Increases

October 9, 2019 • By Caroline Humer

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

August 16, 2019 • By Mary Choy, PharmD, BCGP, FASHP

Adalimumab for JIA-Associated Uveitis: 5-Year Follow-up

July 10, 2019 • By Lara C. Pullen, PhD

Ixekizumab vs. Adalimumab for PsA: How Do They Compare?

July 1, 2019 • By Michele B. Kaufman, PharmD, BCGP

The Rescue: Moving RA Patients from Adalimumab to Baricitinib

June 25, 2019 • By Lara C. Pullen, PhD

Biological DMARDs in Elderly RA Patients: Use, Maintenance & Discontinuation

June 17, 2019

MicroOne / shutterstock.com

Rheumatology Drugs at a Glance, Part 2: Psoriasis

May 17, 2019 • By Mary Choy, PharmD, BCGP, FASHP

1
2
3
…
8
Next Page »